Grand Pharmaceutical Group Limited (HKG:0512)

HKG:0512 Revenue

Grand Pharmaceutical Group had revenue of 6.39B HKD in the half year ending June 30, 2026, with 5.65% growth. This brings the company's total for the last twelve months to 12.48B, up 5.91% year-over-year. In the year 2025, Grand Pharmaceutical Group had annual revenue of 12.28B with 5.48% growth. That makes Grand Pharmaceutical Group the 5,760th largest company in the world by revenue and 371st in Hong Kong.

• Revenue (ttm): 12.48B
• Revenue Growth: +5.91%
• P/S Ratio: 1.28
• Revenue / Employee: 1.01M
• Employees: 12,326
• Market Cap: 15.43B

Revenue Chart

Chart

Chart

Revenue by Geography

Chart

• The People's Republic of China (PRC) 10.63B 86.5%
• America 759.42M 6.2%
• Europe 432.68M 3.5%
• Asia Other than The People's Republic of China (PRC) 408.91M 3.3%
• Others 56.16M 0.5%

Fiscal year ended Dec 31, 2025 See the full HKG:0512 breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	12.28B	638.38M	5.48%
Dec 31, 2024	11.64B	1.12B	10.59%
Dec 31, 2023	10.53B	967.31M	10.12%
Dec 31, 2022	9.56B	964.31M	11.22%
Dec 31, 2021	8.60B	2.25B	35.34%

Data Source: S&P Global Market Intelligence Last updated: Sep 24, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Oct 21, 2026

Data Sources Report a data error